Breakeven Date Change • May 20
No longer forecast to breakeven The 8 analysts covering Verano Holdings no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$28.4m in 2028. New consensus forecast suggests the company will make a loss of US$33.7m in 2028. Announcement • May 14
Verano Holdings Corp Submits Dea Registration Applications for State-Licensed Medical Cannabis Businesses Verano Holdings Corp. announced the Company has submitted applications with the U.S. Drug Enforcement Agency to register certain state-licensed medical cannabis operations, pursuant to the expedited registration pathway provided by the federal rescheduling of medical marijuana to Schedule III of the Controlled Substances Act. Verano’s active operations span 13 U.S. states, comprised of 162 Zen Leaf and MÜV dispensaries and 14 production facilities with more than 1.1 million square feet of cultivation capacity. Announcement • May 02
Verano Holdings Corp., Annual General Meeting, Jun 18, 2026 Verano Holdings Corp., Annual General Meeting, Jun 18, 2026. Announcement • May 01
Verano Holdings Corp. (NEOE:VRNO) announces an Equity Buyback for 18,219,090 shares, representing 5% for $20 million. Verano Holdings Corp. (NEOE:VRNO) announces a share repurchase program. Under the program, the company will repurchase up to 18,219,090 shares, representing 5% of its issued share capital, for $20 million. The purchases may be made from time to time over a period of 12 months ending April 30, 2027. As of March 31, 2026, the company had 364,343,003 outstanding shares. Announcement • Mar 25
Verano Holdings Corp. to Report Q1, 2026 Results on Apr 30, 2026 Verano Holdings Corp. announced that they will report Q1, 2026 results Pre-Market on Apr 30, 2026 Announcement • Mar 14
Verano Holdings Corp. Reports Unaudited Consolidated Loss on Impairment for the Fourth Quarter Ended December 31, 2025 Verano Holdings Corp. reported unaudited consolidated loss on impairment for the fourth quarter ended December 31, 2025. For the quarter, the company reported loss on impairment of intangibles – goodwill of $86,591,000 and loss on impairment of intangibles – license & fixed assets of $90,849,000 compared to loss on impairment of intangibles – goodwill of $8,179,000 and loss on impairment of intangibles – license & fixed assets of $319,520,000 a year ago. Announcement • Mar 06
Verano Holdings Corp. to Report Q4, 2025 Results on Mar 12, 2026 Verano Holdings Corp. announced that they will report Q4, 2025 results Pre-Market on Mar 12, 2026 Announcement • Jan 14
Verano Holdings Corp. Announces Launch of Swift Lifts as Standalone Pre-Roll Brand Verano Holdings Corp. announced the launch of Swift Lifts as an independent brand, offering a robust line-up of premium pre-roll offerings that are perfectly portioned and designed to deliver quality and convenience. Formerly part of the Verano namesake brand portfolio, the new Swift Lifts branded pre-rolls will initially be available for purchase at Verano's Zen Leaf dispensaries and third-party partners in five core Verano markets - Arizona, Illinois, Maryland, New Jersey and Nevada - with plans to scale to Connecticut, Virginia, and MUV dispensaries in Florida, in the future. The Swift Lifts brand rollout demonstrates Verano's ongoing focus on delivering strategic new product innovation in rapidly-expanding cannabis categories. Pre-rolled joints continue to be the fastest-growing product category in the industry, growing over 22% in 2025 compared to the prior year, and accounting for over 13% of total 2025 cannabis sales1. The new Swift Lifts product line includes: Short Lifts: Short Lifts are all about convenience without compromising quality. These pre-rolls are small in size but big on flavor, making them ideal for on-the-go moments or quick solo enjoyment. Each pack contains ten 0.35g pre-rolls, delivering smooth, approachable hits that are perfect for short sessions. Swift Lifts: Swift Lifts make getting lifted effortless. Perfectly balanced for potency and flavor, Swift Lifts are designed to fit seamlessly into any lifestyle. No fuss, no prep - just light up and enjoy. Each pack includes five 0.5g pre-rolls, deliver smooth, consistent hits that keep the day moving. Long Lifts: Long Lifts offer a full-gram experience perfect for slow, relaxing sessions. Each one-gram pre-roll burns evenly and delivers smooth, rich flavor from start to finish. Designed for extended enjoy, they're ideal for unwinding solo or sharing with friends. Following the initial roll out, a large expansion of infused and coated Swift Lifts products will be available in select markets, including Diamond Infused Swift and Long Lifts, and Infused & Coated Short and Long Lifts. Announcement • Dec 03
Verano Holdings Corp. Receives Conditional License from Texas Department of Public Safety to Commence Vertical Cannabis Operations in Texas Verano Holdings Corp. announced the Texas Department of Public Safety has awarded Verano a conditional Dispensing Organization License as part of the state’s Phase 1 expansion process. Subject to final approval by the Texas Department of Public Safety after it completes further due diligence, the license grants Verano permission to cultivate, process and dispense medical cannabis for Texas patients. Verano’s current operations span 13 states, comprised of 158 Zen Leaf and MÜV cannabis dispensaries, and 15 cultivation and processing facilities with over 1.1 million square feet of cultivation capacity. Announcement • Oct 29
Vireo Growth Inc. and Verano Holdings Corp. Reaches Comprehensive Settlement Dismissing All Outstanding Litigation Matters Vireo Growth Inc. and Verano Holdings Corp. on October 29, 2025 announced that they have reached a comprehensive settlement dismissing all outstanding litigation matters between the two Companies that are pending before the Supreme Court of British Columbia, Canada. The terms of the Settlement Agreement were approved by the respective Boards of Directors of both Companies. The value of the settlement to Vireo is approximately USD 10 million consisting of the acquisition of certain real estate assets and USD 1 million in cash. The resolution marks the conclusion of a complex legal chapter and reflects a commitment by both Companies to move forward in a constructive manner. Both Companies reiterated their dedication to delivering long-term value to their shareholders and quality products and services to their customers. Announcement • Oct 16
Verano Holdings Corp. Elevates Expanding Vape Product Portfolio with Exclusive, First-To-Market Launch of Revolutionary HYPHEN System Verano Holdings Corp. announced the launch of HYPHEN, driving further momentum for the Company's expanding vape portfolio with the exclusive rollout of HYPHEN's all-in-one pod system. With a modular battery design that utilizes pod-functionality to serve multiple oil and volume categories within the same base unit, HYPHEN offers consumers the freedom and flexibility to use a variety of oils, sizes and formats without the hassle of juggling between different devices. Beginning October 18, HYPHEN will hit dispensary shelves across a number of the nation's largest cannabis markets - starting with Zen Leaf dispensaries and third-party retailers in Arizona, Illinois, Maryland and New Jersey, with plans to introduce it to Connecticut, Florida, Nevada, Ohio, Pennsylvania, Virginia and West Virginia thereafter. HYPHEN units will include a side-bar battery and pod - available in 1-gram (the) Essence and 2-gram Savvy pods - and individual pods will be available for purchase at a later date. Featuring 20 top-performing strains, (the) Essence pods will feature powerhouse strains including Pineapple Express and Gelato, with Savvy pods leaning on consumer-loved flavor profiles with a cannabis twist, such as Grape Kush and Blue Raz Haze. Demonstrating its cutting-edge versatility, to preserve each extract's unique profile and produce optimal flavor and vapor, HYPHEN's proprietary modular battery offers a pre-heat option and three temperature settings, providing consumers the ability to cycle through each setting by removing and reinserting the pod for the ideal consumption temperature. Each device includes an embedded NFC chip, which allows users to simply tap their smartphone to get plugged into exciting deals and promotions. Announcement • Sep 25
Verano Holdings Corp. to Report Q3, 2025 Results on Oct 29, 2025 Verano Holdings Corp. announced that they will report Q3, 2025 results Pre-Market on Oct 29, 2025 Announcement • Aug 07
Verano Holdings Corp. Announces Resignation of Darren Weiss as President Verano Holdings Corp. announced the resignation of Darren Weiss from his role as Company President to pursue business opportunities in the cannabis industry outside of North America. Weiss joined Verano as General Counsel in 2017, and subsequently served in leadership positions including Chief Legal Officer, Chief Operating Officer and most recently, President. Throughout his tenure, his industry knowledge and unique blend of legal and operations expertise helped scale Verano from a startup into one of the largest multi-state cannabis operators in the industry. In addition to his other business ventures, Weiss will remain engaged with the Company as a consultant providing business development and other services to Verano outside of North America, including giving Verano a right of first refusal on business opportunities he may initiate, source, or participate in. Announcement • Jul 15
Verano Holdings Corp. Announces Promotion and Appointment of James Leventis as Chief Strategy and Compliance Officer, Effective on July 1, 2025 Verano Holdings Corp. announced the promotion and appointment of James Leventis as the Company’s Chief Strategy and Compliance Officer, effective as of July 1, 2025. As the newest member of Verano’s executive leadership team, Leventis will provide strategic leadership over the Company’s robust regulatory, licensing, compliance and government affairs activities across its expanding national footprint. Since joining the Company in 2019, he has played a critical role driving Verano’s growth from a single-state operator to one of the industry’s largest publicly traded companies. A seasoned cannabis executive and licensed attorney, Leventis most recently served as Executive Vice President of Legal, Regulatory and Government Affairs for the Company, and his nearly 15-year career spans a variety of disciplines including regulatory, compliance, M&A and licensing in the healthcare, pharmaceutical, consulting and cannabis sectors. Leventis also plays a pivotal external role advocating for cannabis reform at the state and federal levels. Throughout his tenure, he has served as a founding member and executive officer on a number of boards, trade associations and political action committees, including the United States Cannabis Roundtable, the American Rights and Reform PAC, the American Trade Association of Cannabis and Hemp, and more. Announcement • Jul 02
Verano Holdings Corp. to Report Q2, 2025 Results on Aug 07, 2025 Verano Holdings Corp. announced that they will report Q2, 2025 results Pre-Market on Aug 07, 2025 Announcement • Apr 15
Verano Holdings Corp. Announces Chief Financial Officer Changes Verano Holdings Corp. announced the promotion and appointment of Richard Tarapchak as the Company’s Chief Financial Officer (‘CFO’), effective as of April 11, 2025. Tarapchak succeeds Brett Summerer, former Chief Financial Officer, who is departing the Company following his mutually agreed upon resignation. As CFO and a member of Verano’s executive leadership team, Tarapchak, a seasoned financial executive with over three decades of experience, will oversee all financial and accounting operations, strategic financial planning, and information technology for the Company. He joined Verano in July of 2022, and has served as Verano’s Executive Vice President, Finance and Corporate Controller and Principal Accounting Officer throughout his tenure with the Company. Prior to joining Verano, Tarapchak held a variety of accounting and finance leadership positions across a diverse set of industries. His extensive experience includes serving as Vice President, Corporate Controller and Chief Accounting Officer of II-VI Incorporated; Corporate Controller of Reynolds Group Holdings Limited; Chief Financial Officer of National Material L.P.; and several positions at Navistar International Corporation, including, most recently, Senior Vice President and Corporate Controller. Tarapchak earned a business administration degree from Wittenberg University in 1987 and an MBA in finance and accounting from The Ohio State University in 1992. In addition, he is a certified public accountant, and serves as the Chair of the Corporate Controller’s Council at the Manufacturers Alliance and as a board member of the Illinois CPA Society. Announcement • Apr 04
Verano Holdings Corp. to Report Q1, 2025 Results on May 08, 2025 Verano Holdings Corp. announced that they will report Q1, 2025 results Pre-Market on May 08, 2025 Announcement • Mar 21
Verano Holdings Corp., Annual General Meeting, Jun 19, 2025 Verano Holdings Corp., Annual General Meeting, Jun 19, 2025. Announcement • Mar 13
Verano Targets Fastest-Growing Categories with Expansion of Savvy™ and (the) Essence™ Product Portfolios in Leading Cannabis Markets Verano Holdings Corp. announced the launch of a wave of new product innovation across the fastest-growing categories in key markets, including Extra Savvy 2-gram vape cartridges; Savvy Strut 2-gram all-in-one vapes; Savvy 100 Proof diamond-infused barrel-style pre-rolled joints; and (the) Essence J’s barrel-style pre-rolled joints. Pre-rolled joints and vapes represent the fastest-growing categories in the industry, and the larger-format vape category specifically grew more than 400% in 20241. Demonstrating Verano’s focus on innovation, automation and differentiation, the Company is moving with speed and agility to meet consumer demand by leveraging in-house talent and cutting-edge manufacturing technology that exponentially increases production efficiency and output while preserving quality. The full suite of new Savvy and (the) Essence products will be available for purchase at Verano’s Zen Leaf™ and MÜV™ locations, along with third-party dispensary partners, in select states. Extra Savvy 2-gram vape cartridges: Stacked with high potency oil and tasty terps to hit harder, last longer and stretch cash. Perfect for seasoned consumers who value potency, longevity and consistency in their vapes. Extra Savvy is currently available in five strains: Sour Tangie, White Widow, Bacio Gelato, Rainbow Belts and GMO. Now available in Illinois, New Jersey, Maryland and Arizona; coming soon to Pennsylvania, Florida and Connecticut. Savvy Strut 2-gram all-in-one vapes: The 2-gram all-in-one that delivers big clouds and bold flavors. Built to max out and make every drop count, with its USB-C compatibility, lit oil window and dynamic airflow for trouble-free vaping, Savvy Strut is perfect for consumers who value portability, longevity and consistency in their vapes. Each device includes an embedded NFC chip, which allows users to simply tap their smartphone to get plugged into exciting deals and promotions. Savvy Strut is currently available in six strains: Juicy Mango, Summer Melon, Peaches & Cream, Pineapple Mimosa, Fresh Berry and Rainbow Sherbet. Now available in Illinois, New Jersey, Maryland and Arizona; coming soon to Pennsylvania and Florida. Savvy 100 Proof diamond-infused barrel-style pre-rolled joints: Locked and loaded for a heavier hit, Savvy 100 Proof is crafted by blending pre-ground small bud flower with superfine, isolated THCa diamonds. This infusion process ensures a seamless blend of beloved Savvy strains with the THCa diamonds, delivering a uniquely potent experience. Now available in Illinois and New Jersey. (the) Essence J’s barrel-style pre-rolled joints: Tapping into the industry’s fastest-growing category, (the) Essence J’s harness the power of cutting-edge manufacturing innovation that exponentially increases output while incorporating a unique yet recognizable barrel-style shape, delivering consumer affordability without sacrificing quality. Now available in Illinois and New Jersey; coming soon to Florida. Announcement • Feb 11
Verano Holdings Corp. to Report Q4, 2024 Results on Feb 27, 2025 Verano Holdings Corp. announced that they will report Q4, 2024 results Pre-Market on Feb 27, 2025 Reported Earnings • Nov 08
Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.052 loss in 3Q 2023) Third quarter 2024 results: US$0.12 loss per share (further deteriorated from US$0.052 loss in 3Q 2023). Revenue: US$216.7m (down 9.7% from 3Q 2023). Net loss: US$42.6m (loss widened 139% from 3Q 2023). Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Pharmaceuticals industry in Germany. Announcement • Oct 26
Verano Commences Adult Use Cannabis Sales At Zen Leaf Waterbury in Connecticut Verano Holdings Corp. announced the Company’s Zen Leaf Waterbury dispensary in Connecticut has received all required approvals from municipal and state officials to commence adult use sales. Zen Leaf Waterbury, located at 237 East Aurora Street, is open Monday through Saturday from 8 a.m. to 8 p.m. for medical patients and 10 a.m. to 8 p.m. for adult use guests. Following a ceremonial ribbon cutting with representatives of the Waterbury Chamber of Commerce at 10:30 a.m. on October 25th, guests visiting Zen Leaf Waterbury throughout the grand opening celebration weekend will be greeted by complimentary coffee and donuts, a food truck serving Connecticut’s famous Ted’s steamed cheeseburgers, a live glassblowing demonstration, and discounted specials on CTPharma products. Additionally, Zen Leaf Waterbury will offer promotions available every day across all Connecticut Zen Leaf locations, including the state’s leading 22% off discount for Veterans, 20% off “Medical Monday” discounts for medical patients, and up to 20% off the first three orders after downloading the Zen Leaf mobile app. Zen Leaf Waterbury will also offer an array of enhanced features and conveniences for cannabis consumers, including digital kiosks for convenient ordering, an additional 95 parking spaces, and access to the Company’s Cabbage Club membership program to redeem the full range of exclusive membership discounts and benefits. Announcement • Oct 04
Verano Holdings Corp. to Report Q3, 2024 Results on Nov 07, 2024 Verano Holdings Corp. announced that they will report Q3, 2024 results Pre-Market on Nov 07, 2024 New Risk • Sep 01
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable next year (US$48m net loss next year). Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Significant insider selling over the past 3 months (€1.0m sold). Reported Earnings • Aug 08
Second quarter 2024 earnings released: US$0.063 loss per share (vs US$0.038 loss in 2Q 2023) Second quarter 2024 results: US$0.063 loss per share (further deteriorated from US$0.038 loss in 2Q 2023). Revenue: US$222.4m (down 5.0% from 2Q 2023). Net loss: US$21.8m (loss widened 67% from 2Q 2023). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in Germany. Announcement • Aug 05
Verano Holdings Corp. Announces to Commence Adult Use Cannabis Sales in Ohio on August 6, 2024 Verano Holdings Corp. announced that after obtaining all required approvals, the Company will commence adult use cannabis sales in Ohio on August 6, 2024 at four of its five nationwide Zen Leaf retail locations in Bowling Green, Canton, Cincinnati, and Dayton, with its Newark location expected to follow pending approval from state officials. Verano offers a wide range of high quality cannabis products sold at its Zen Leaf Ohio locations and third-party retailers throughout the state, including Verano™ Reserve flower; Savvy™ and Nectar flower, vaporizers, and cured resin edibles and extracts; BITS™ low-dose, high-function edibles; Encore™ Edibles hand-crafted cannabis gummies, hard candies, mints, caramels and chocolates; and Avexia™ topical lotion, balm, bath soaks, tinctures, and RSO products that are made to effortlessly enhance any self-care routine. Announcement • Jul 04
Verano Holdings Corp. to Report Q2, 2024 Results on Aug 07, 2024 Verano Holdings Corp. announced that they will report Q2, 2024 results Pre-Market on Aug 07, 2024 Announcement • Jun 18
Verano Holdings Corp. (NEOE:VRNO) announces an Equity Buyback for 17,320,857 shares, representing 5% for $50 million. Verano Holdings Corp. (NEOE:VRNO) announces a share repurchase program. Under the program, the company will repurchase up to 17,320,857 Class A subordinate voting shares, representing 5% of the issued and outstanding shares for $50 million. The program will be valid till June 13, 2025. Announcement • May 09
Verano Holdings Corp. Provides Revenue Guidance for the Second Quarter 2024 Verano Holdings Corp. provided revenue guidance for the second quarter 2024. The Company issued flat to low single-digit revenue growth guidance for the second quarter 2024. Reported Earnings • May 08
First quarter 2024 earnings released: US$0.014 loss per share (vs US$0.027 loss in 1Q 2023) First quarter 2024 results: US$0.014 loss per share (improved from US$0.027 loss in 1Q 2023). Revenue: US$221.3m (down 2.5% from 1Q 2023). Net loss: US$4.82m (loss narrowed 48% from 1Q 2023). Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Pharmaceuticals industry in Germany. Announcement • Apr 04
Verano Holdings Corp. to Report Q1, 2024 Results on May 08, 2024 Verano Holdings Corp. announced that they will report Q1, 2024 results Pre-Market on May 08, 2024 Announcement • Mar 27
Verano Holdings Corp., Annual General Meeting, Jun 20, 2024 Verano Holdings Corp., Annual General Meeting, Jun 20, 2024. New Risk • Mar 25
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 17% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$226m net loss in 2 years). Shareholders have been diluted in the past year (4.8% increase in shares outstanding). Reported Earnings • Mar 05
Full year 2023 earnings released: US$0.33 loss per share (vs US$0.81 loss in FY 2022) Full year 2023 results: US$0.33 loss per share (improved from US$0.81 loss in FY 2022). Revenue: US$938.5m (up 6.7% from FY 2022). Net loss: US$112.7m (loss narrowed 58% from FY 2022). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Pharmaceuticals industry in Germany. 
